REQUEST A DEMO
Total
USD $0.00
Search more companies

Optimapharm D.O.O. Beograd (Serbia)

Main Activities: Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Full name: Optimapharm D.O.O. Beograd Profile Updated: October 16, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

Optimapharm D.O.O. Beograd is an enterprise located in Serbia, with the main office in Belgrade. The enterprise operates in the Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) industry. Optimapharm D.O.O. Beograd was incorporated on 2008. It currently has a total number of 32 (2023) employees. From the latest financial highlights, Optimapharm D.O.O. Beograd reported a net sales revenue increase of 14.76% in 2023. A growth of 19.24% was recorded in its total assets. The enterprise’s net profit margin increased by 0.42% in 2023.

Headquarters
Vaska Pope 10
Belgrade; Belgrade; Postal Code: www.optimapharm.eu

Contact Details: Purchase the Optimapharm D.O.O. Beograd report to view the information.

Website: http://CUBE_PROFILES_YU

Basic Information
Total Employees:
Purchase the Optimapharm D.O.O. Beograd report to view the information.
Outstanding Shares:
Purchase the Optimapharm D.O.O. Beograd report to view the information.
Registered Capital:
Purchase the Optimapharm D.O.O. Beograd report to view the information.
Incorporation Date:
2008
Key Executives
Purchase this report to view the information.
Director
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Optimapharm D.O.O. Beograd report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency RSD. Absolute financial data is included in the purchased report.
Net sales revenue
14.76%
Total operating revenue
14.76%
Operating profit (EBIT)
35.16%
EBITDA
32.79%
Net Profit (Loss) for the Period
23.2%
Total assets
19.24%
Total equity
35.91%
Operating Profit Margin (ROS)
1.1%
Net Profit Margin
0.42%
Return on Equity (ROE)
-2.36%
Quick Ratio
0.03%
Cash Ratio
0.04%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?